Press Releases

All Releases
View Summary Ironwood Presents Gastrointestinal Disease Research at Digestive Disease Week® 2015
May 13, 2015
PDF 160.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 7, 2015
PDF 14.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2015 Investor Update
May 5, 2015
PDF 176.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Appoints Lawrence Olanoff, M.D., Ph.D., to Board of Directors
Apr 16, 2015
PDF 17.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host First Quarter 2015 Investor Update Call
Apr 15, 2015
PDF 15.2 KB Add to Briefcase
View Summary Exact Sciences and Ironwood Pharmaceuticals Enter Co-Promotion Agreement for Cologuard®
Mar 9, 2015
PDF 162.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Initiates Phase I Clinical Study of sGC Stimulator IW-1973
Mar 5, 2015
PDF 111.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Mar 4, 2015
PDF 14.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference
Feb 23, 2015
PDF 14.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Fourth Quarter 2014 Investor Update
Feb 12, 2015
PDF 180.2 KB Add to Briefcase
View Summary Ironwood Reports Positive Top-Line Data from Exploratory Phase IIa Trial Of IW-3718 in Refractory Gastroesophageal Reflux Disease
Feb 4, 2015
PDF 112.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Fourth Quarter 2014 Investor Update Call
Jan 29, 2015
PDF 15.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 5, 2015
PDF 15.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Initiates Phase IIa Clinical Study of IW-9179 in Diabetic Gastroparesis
Dec 9, 2014
PDF 111.2 KB Add to Briefcase
View Summary Ironwood Earns $15 Million Milestone from Astellas upon Initiation of Enrollment in Linaclotide Phase III IBS-C Clinical Trial in Japan
Nov 20, 2014
PDF 110.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference
Nov 5, 2014
PDF 14.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation
Nov 4, 2014
PDF 156.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Third Quarter 2014 Investor Update
Nov 4, 2014
PDF 177.4 KB Add to Briefcase
View Summary Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting
Oct 20, 2014
PDF 111.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Initiation of Phase II Trial of Linaclotide in Adult Patients with Opioid-Induced Constipation
Oct 16, 2014
PDF 155.9 KB Add to Briefcase
Showing 81-100 of 237 Page: 1 2 3 4 5 6 7 8 9 ... 12  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.